Description
An inhibitor of fatty acid synthase (IC50 = 7.7 nM in an assay detecting released CoA); selective for the KR domain over the KS domain of FASN (IC50s = 29 and >10,000 nM, respectively); decreases incorporation of 13C-labeled acetate into cellular lipids in a dose-dependent manner in KATO-III, MKN-45, and SNU-1 gastric, and A549 non-small cell lung cancer cell lines; reduces cell growth of A549 cells (EC50 = 15 nM)
Formal name: 4-[4-(5-benzofuranyl)phenyl]-5-[[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
Synonyms:
Molecular weight: 428.5
CAS: 1332331-08-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer